Biogen’s early R&D chief exits for ARCH and Bezos-backed anti-aging biotech
The Biogen mini-exodus continues, this time leading to a pair of big Silicon Valley names: Jeff Bezos and Robert Nelsen.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.